Low-Cost Portable Inhalation Therapy Platform for Needle-Free DNA-Based Influenza Vaccination [ 2016 - 2018 ]

Research Grant

Researchers: Prof Leslie Yeo (Principal investigator) ,  A/Pr Aeron Hurt ,  A/Pr David Morton ,  A/Pr David Piedrafita

Brief description Influenza affects a large proportion of the global population and can result in many deaths in a pandemic. A DNA influenza vaccine overcomes the possibility of severe side effects associated with commonly used vaccines based on weakened viruses and can be rapidly produced and easily transported without refrigeration. DNA vaccines are however unstable and difficult to deliver. We propose to address this with a low-cost and portable handheld device which allows the vaccine to simply be inhaled.

Funding Amount $AUD 539,820.31

Funding Scheme Development Grants

Notes Development Grant